Introduction
Flutamide, 3'-trifluoromethyl-4'-nitro-2-methylpropinoylanilide, is a nonsteroidal antiandrogen [1, 2] devoid of other hormonal activity and is recognized worldwide as the most beneficial drug for the treatment of patients with advanced prostate cancer [3] [4] [5] when used in combination with various luteinizing hormone-releasing factor agonists. This antiandrogen is also used in combination with oral contraceptives for the treatment of hirsutism [6] and benign prostatic hyperplasia [7, 8] . However, flutamide therapy is associated with hepatitis in a few subjects. The incidence of liver toxicity (as defined by an increase in serum transaminase activity of fourfold greater than upper normal limits) was found to be 0.36% in 1091 consecutively treated prostate cancer patients [9] [10] [11] . Flutamide-induced hepatitis was decreased using piperonyl butoxide [cytochrome P450 (CYP450) inhibitor] and increased using β-naphthoflavone (CYP450 1A inducer) [12] . Previous results show that CYP1A2 is involved in flutamide bioactivation [12, 13] . CYP1A2 is a cytochrome P-450 enzyme constitutively expressed in the liver, which catalyzes the metabolism of many drugs, such as caffeine, phenacetin, and propranolol [14] . The enzyme also participates in the metabolic activation of chemical mutagens in cooked food such as 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3, 8-dimethylimidazo [4,5- f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine [15] . Previous studies have reported flutamide bioactivation using the P450 enzyme system generated a nitro anion free radical after treatment [16] . These radicals can bind covalently to proteins and lipids, or remove hydrogen atoms from polyunsaturated fatty acids in lipids, thereby initiating lipid peroxidation and liver cell injury [17] . Therefore, CYP1A2 increase might be a risk factor for flutamide-associated hepatotoxicity or carcinogenicity. In the present study, we investigate the modulation of CYP1A2 expression in adult male rats given flutamide for 2 weeks. obtained from frozen rat livers (0.5 g-1 g) using Trizol reagent. The RNA concentration was determined spectroscopically at 260 nm, and 5 µg of total RNA was taken for reverse transcription. Random primer (300 ng) was added and primer annealing was performed using incubation for 10 min at 65 °C and 10-min progressive cooling on ice. Deoxynucleotides (dNTP) (4 mmol/L each), 5 µL of 10×reaction buffer, 50 U of block ribonuclease inhibitor, and 200 U of SuperScript II RNase reverse transcriptase were added to a final volume of 50 µL, and samples were incubated at 42 °C for 30 min. The reaction was stopped by heating to 90 °C for 5 min. Control samples contained distilled water instead of RNA. The synthesized cDNA was stored at -20 °C until use. Polymerase chain reaction Reverse transcription sample of 2.5 mL was added to the corresponding polymerase chain reaction mixture containing 0.5 µmol/L sense and antisense primer, 2 mmol/L MgCl 2 , 10 mmol/L Tris-HCl (pH 9), 50 mmol/L KCl, 0.1% Triton X-100, and 80 µmol/L dNTP. After heating at 95 °C for 5 min and cooling to the primer-annealing temperature for 5 min (60 °C), 2 U of Taq DNA polymerase was added. The following primers were used: CYP1A2 forward (+127 to +147), 5'-GGACCCTGGGGCTTGCCCTTC-3'; reverse (+484 to +504), 5'-AGCCTCTTTGCTCACGTGCTC-3'; β-actin forward (+59 to +69), 5'-CCCAAGTCGCCTCC-GTCCCGC-3'; reverse (+894 to +914), 5´-CCCTCCAGGAGCCCCATGAGC-3'. The specificity of CYP1A2 primers was confirmed through alignment with the CYP subfamily DNAs. Amplification conditions for all primer pairs were used as follows: 94 °C 30 s, 60 °C 30 s, and 72 °C 30 s for 30 cycles. β-actin segment was amplified separately and used as an external standard, because interaction of primer pairs caused a decrease in signal intensity. A total 12 µL of each preparation was subjected to agarose gel electrophoresis in the presence of ethidium bromide. The gel was photographed using Polaroid 665 film and the intensity of each band was quantified using the software provided with the ABI 7700 system. Each assay was performed in triplicate. Results were expressed as a ratio of the optical intensity of the CYP1A2 to that of the β-actin. This approach allows for the semiquantita-tion of the expression of the CYP1A2 gene.
Materials and methods

Chemicals
Immunoblot analysis Liver microsomes were prepared as described by Kamataki and Kitagawa [18] . The protein concentration was determined using Bradford's method [19] , using a protein assay with bovine serum albumin as a standard. Three micrograms of microsomal protein were resolved separately by electrophoresis on 10% SDS-polyacrylamide gel and then transferred onto a nitrocellulose membrane. The membrane was incubated with a rabbit anti-rat CYP1A2 monoclonal antibody, and further incubated with goat anti-rabbit secondary antibody conjugated with horseradish peroxidase, followed by detection with 3,3'-diaminobenzidine and hydrogen peroxide. The membrane was scanned with an image scanner, and the signal intensity was quantified using the software provided with the ABI 7700 system. In the present study, the levels of CYP1A2 proteins were in the linear range for densitometric readings.
CYP1A2 activity Caffeine was used as a probe for CYP1A2 activity and plasma caffeine (137X) and its metabolite (17X) were assayed using high performance liquid chromatography [20] . After the last dose of flutamide and overnight fast, each rat received 20 mg/kg (ip) of caffeine. Blood samples (2 mL) were drawn after caffeine administration. Plasma was separated and frozen at -20°C for later analysis. The mixtures of plasma containing 17X and 137X was extracted with chloroform/isopropanol (9:1). The residue remaining after evaporation was dissolved in 0.1 mL elution and 20 µL was injected into the chromatographic system. HT was chosen as an internal standard (IS). All components were separated isocratically on a reversed-phase column using 0.05% acetic acid:acetonitrile:methanol (82:8:10) as a mobile phase at a flow rate of 1 mL/min. Ultraviolet detection wavelength was 282 nm. The retention times for 17X, 137X, and IS were 4.50 min, 5.03 min, and 8.13 min, respectively. The CYP1A2 activity was expressed as a ratio of the concentration of 17X to that of 137X observed 6 h after giving caffeine.
Statistical analysis
The statistical significance of the difference between the means of the two groups was assessed using the independent t test (SPSS software package, 1997). P<0.05 was considered statistically significant.
Results
CYP1A2 mRNA levels The levels of CYP1A2 mRNA were normalized using a comparison with β-actin, constitutively expressed in the rat liver. The increase in CYP1A2 mRNA was expressed as a percentage of the control. After flutamide treatment (50 mg/kg) of rats for 14 d, liver CYP1A2 mRNA levels were similar to control levels, but CYP1A2 mRNA levels were increased 1.86 and 3.11-fold relative to controls in rats in flutamide 100 mg/kg and 200 mg/kg group, respectively. CYP1A2 mRNA levels were increased 15.6-fold by 3-MC treatment (Figure 1 ).
CYP1A2 protein
Similar results were obtained for the analysis of the P450 protein. After 50 mg/kg flutamide treatment, CYP1A2 protein in rat liver microsomes was similar to that in the control group. However, CYP1A2 protein levels increased 1.78 and 2.89-fold respectively, after 100 mg/kg and 200 mg/kg flutamide treatment as compared to those in controls. In contrast, 3-MC treatment increased the CYP1A2 protein content 13.8-fold (Figure 2 ).
CYP1A2 enzyme activity
Caffeine is hydroxylated to form paraxanthine (17X) using CYP1A2. Concentration ratio of caffeine metabolite paraxanthine to caffeine (17X/137X) was used to express the activity of CYP1A2. After giving caffeine for 6 h, CYP1A2 activity in rats treated with flutamide (50 mg/kg) was similar to that in the control group. In rats given 100 mg/kg and 200 mg/kg of flutamide, CYP1A2 enzyme activity increased 1.65 and 2.83-fold, respectively, as compared to that in the control group. 3-MC increased CYP1A2 activity 8.50-fold more than those in the control group (Figure 3) .
Discussion
In the present study, CYP1A2 mRNA, protein, and enzyme activity were induced by flutamide treatment in rats. mRNA levels in rats. (A) Total RNA was extracted from liver tissues, CYP1A2 and β-actin mRNA levels were detected using reverse transcription-polymerase chain reaction. Each lane contains 1 µg total of RNA from the liver of the control rats, flutamide and 3-MC treated rats. Lane 1 corresponds to the control liver, whereas lanes 2, 3, and 4 correspond to liver RNA from rats treated with flutamide at 50 mg/kg, 100 mg/kg, and 200 mg/kg, respectively. Lane 5 corresponds to liver RNA from the 3-MC treated rats. (B)Signal intensity was quantified by a bioimage analyzer (n=10). The signals were normalized using β-actin. The columns represent the induction (fold) of CYP1A2 mRNA relative to the control. It is reasonable to speculate that flutamide is a CYP1A2 inducer in rats. This P450 induction is dose-dependent as it increases with increasing amounts of flutamide in the liver. The magnitude of CYP1A2 induction assessed using three different parameters, that is, mRNA, protein, and enzyme activity, was found to be comparable. The differences between the mRNA and protein induction and between protein and enzyme activity in rats were less than 2-fold; therefore, it is highly probable that the CYP1A2 induction occurs mainly at a pretranslational level, and we speculate that flutamidemediated CYP1A2 induction is a result of increased rate of transcription.
CYP1A2 is one of the major constitutively expressed P-450 in the liver tissue. It catalyzes steroid hydroxylations, such as 17β-estradiol 2-hydroxylation [21, 22] . Of considerable interest is the ability of P4501A2 to catalyze the N-hydroxylation of carcinogenic aryl amines and heterocyclic amines [23] [24] [25] . The oxidized products can modify DNA, either directly or following conjugation with acryl or sulfate groups [26, 27] . The heterocyclic amines are of considerable interest in that they are found in charbroiled food and cigarette smoke. There is some epidemiological evidence that elevated levels of CYP1A2 can be a predisposing factor to colon cancer, although the risk is marginal unless high levels of N-acetyltransferase are present along with high charbroiled meat consumption.
Flutamide can be metabolized by CYP1A2 to form the reactive metabolites. Nitro radical and one-electron reduction products have toxic effects on the liver cells [16] . Induction of CYP1A2 can increase the formation of toxic metabolites, and increase the incidence of liver toxicity. This might explain why flutamide had no significant liver toxicity after low doses (50 mg/kg), although it caused liver toxicity at higher doses (100 mg/kg and 200 mg/kg) in previous studies [28] . Therefore, the induction of CYP1A2 might have a large influence on the therapeutic efficacy and liver toxicity associated with flutamide treatment. Induction of CYP1A2 using flutamide treatment and its possible effects on the metabolism of other drugs and the carcinogenesis of heterocyclic amines in human beings would be useful topics of further study. 
